My Mindful Moments: A Mindfulness Meditation and Digital Art Activity

NCT ID: NCT04557033

Last Updated: 2022-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-01

Study Completion Date

2022-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this evidence-based practice project is to evaluate the feasibility of providing a relaxation mindfulness meditation and an expressive digital arts activity among clinical staff at Dana Farber Cancer Institute .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project provides an opportunity for patient care staff in an ambulatory oncology setting to participate in and evaluate an activity that includes a mindfulness meditation technique and an expressive digital arts activity.

This study will be conducted to evaluate the feasibility of providing a mindfulness meditation and digital imagery activity.

* The activity will include a guided mindfulness meditation and the creation of a digital image on an iPad.
* Participants will be asked to complete brief surveys before and after the intervention activity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mindfulness Meditation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mindful Meditation

* The activity will include a guided mindfulness meditation and the creation of a digital image on an iPad.
* The My Moments® application (app) is a tool used to facilitate expressive art creation in a digital photography media
* Participants will be asked to complete brief surveys before and after the intervention activity.

Group Type EXPERIMENTAL

Mindfulness intervention

Intervention Type OTHER

My Moments® application (app) is a tool used to facilitate expressive art creation in a digital photography media

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness intervention

My Moments® application (app) is a tool used to facilitate expressive art creation in a digital photography media

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults ≥18 years of age
* Currently employed at Dana Farber Cancer Institute
* Providing patient care on Yawkey

Exclusion Criteria

* Not an employee of Dana Farber Cancer Institute
* Not providing Patient Care on Yawkey
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dana-Farber Cancer Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Theresa Jabaley

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Terri Jabaley, Ph.D, RN

Role: PRINCIPAL_INVESTIGATOR

Dana-Farber Cancer Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dana Farber Cancer Institute

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-420

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.